Alsaleh Aseel, Frost Gary S, Griffin Bruce A, Lovegrove Julie A, Jebb Susan A, Sanders Thomas A B, O'Dell Sandra D
Division of Diabetes and Nutritional Sciences, School of Medicine, King's College London, London, UK.
J Nutrigenet Nutrigenomics. 2011;4(6):354-66. doi: 10.1159/000336362. Epub 2012 Feb 29.
BACKGROUND/AIMS: The peroxisome proliferator-activated receptors (PPARs) are transcriptional regulators of lipid metabolism, activated by unsaturated fatty acids. We investigated independent and interactive effects of PPARγ2 gene PPARG Pro12Ala (rs1801282) andPPARαgene PPARA Leu162Val (rs1800206) genotypes with dietary intake of fatty acids on concentrations of plasma lipids in subjects of whom 47.5% had metabolic syndrome.
The RISCK study is a parallel design, randomised controlled trial. Plasma lipids were quantified at baseline after a 4-week high saturated fatty acids diet and after three parallel 24-week interventions with reference (high saturated fatty acids), high monounsaturated fatty acids and low-fat diets. Single nucleotide polymorphisms were genotyped in 466 subjects.
At baseline, the PPARG Ala12allele was associated with increased plasma total cholesterol (n = 378; p = 0.04), LDL cholesterol (p = 0.05) and apoB (p =0.05) after adjustment for age, gender and ethnicity. At baseline, PPARA Leu162Val × PPARG Pro12Ala genotype interaction did not significantly influence plasma lipid concentrations. After dietary intervention, gene-gene interaction significantly influenced LDL cholesterol (p =0.0002) and small dense LDL as a proportion of LDL (p = 0.005) after adjustments.
Interaction between PPARG Pro12Ala and PPARA Leu162Val genotypes may influence plasma LDL cholesterol concentration and the proportion as small dense LDL after a high monounsaturated fatty acids diet.
背景/目的:过氧化物酶体增殖物激活受体(PPARs)是脂质代谢的转录调节因子,可被不饱和脂肪酸激活。我们研究了PPARγ2基因PPARG Pro12Ala(rs1801282)和PPARα基因PPARA Leu162Val(rs1800206)基因型与脂肪酸饮食摄入量对47.5%患有代谢综合征的受试者血浆脂质浓度的独立和交互作用。
RISCK研究是一项平行设计的随机对照试验。在为期4周的高饱和脂肪酸饮食后以及在采用参考(高饱和脂肪酸)、高单不饱和脂肪酸和低脂饮食进行的三项平行的24周干预后,对血浆脂质进行基线定量。对466名受试者的单核苷酸多态性进行基因分型。
在基线时,校正年龄、性别和种族后,PPARG Ala12等位基因与血浆总胆固醇升高(n = 378;p = 0.04)、低密度脂蛋白胆固醇(p = 0.05)和载脂蛋白B(p = 0.05)相关。在基线时,PPARA Leu162Val×PPARG Pro12Ala基因型相互作用未显著影响血浆脂质浓度。饮食干预后,基因-基因相互作用在调整后显著影响低密度脂蛋白胆固醇(p = 0.0002)和小而密低密度脂蛋白占低密度脂蛋白的比例(p = 0.005)。
PPARG Pro12Ala和PPARA Leu162Val基因型之间的相互作用可能会影响高单不饱和脂肪酸饮食后血浆低密度脂蛋白胆固醇浓度以及小而密低密度脂蛋白的比例。